| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |